⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRBU News
Caribou Biosciences, Inc. Common Stock
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
CRBU
Caribou Biosciences to Participate in Upcoming Investor Conferences
globenewswire.com
CRBU
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
globenewswire.com
CRBU
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
globenewswire.com
CRBU
Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma
globenewswire.com
CRBU